DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in DiaMedica Therapeutics Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −6 vs. Q4 2023
- Shares held
- 4.60M
- +756.5K (+19.7%) vs. Q4 2023
- Total value
- $12.7M
- +$1.82M (+16.7%) vs. Q4 2023
- New holders
- 1
- 7 more added
- Sold out
- 7
- 8 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $87.8M |
| Q1 2026 | 99 | $79.2M |
| Q4 2025 | 92 | $96.0M |
| Q3 2025 | 78 | $82.8M |
| Q2 2025 | 58 | $34.2M |
| Q1 2025 | 57 | $28.5M |
| Q4 2024 | 45 | $36.5M |
| Q3 2024 | 40 | $23.3M |
| Q2 2024 | 32 | $14.9M |
| Q1 2024 | 32 | $12.7M |
| Q4 2023 | 38 | $10.9M |
| Q3 2023 | 36 | $11.0M |
| Q2 2023 | 32 | $15.1M |
| Q1 2023 | 25 | $3.93M |
| Q4 2022 | 28 | $3.99M |
| Q3 2022 | 26 | $3.14M |
| Q2 2022 | 28 | $7.42M |
| Q1 2022 | 34 | $10.0M |
| Q4 2021 | 39 | $14.9M |
| Q3 2021 | 34 | $11.2M |
| Q2 2021 | 43 | $16.9M |
| Q1 2021 | 41 | $52.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 24 | $66 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 175 | $485 | 0.00% | +3+1.7% | Added |
| Federation des caisses Desjardins du Quebec | 230 | $637 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 845 | $2.00K | 0.00% | −237−21.9% | Reduced |
| Advisor Group Holdings, Inc. | 1,000 | $2.77K | 0.00% | 00.0% | Unchanged |
| Legend Financial Advisors, Inc. | 1,000 | $2.77K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 1,070 | $3.88K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,926 | $5.33K | 0.00% | +1,926 | New |
| Tower Research Capital LLC (TRC) | 2,696 | $7.47K | 0.00% | −4,568−62.9% | Reduced |
| Naples Money Management LLC | 2,978 | $8.25K | 0.01% | −900−23.2% | Reduced |
| US Bancorp | 4,335 | $12.0K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 4,824 | $13.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 13,251 | $36.7K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 14,500 | $40.2K | 0.00% | +500+3.6% | Added |
| Jane Street Group, LLC | 15,238 | $42.2K | 0.00% | −8,523−35.9% | Reduced |
| Dimensional Fund Advisors LP | 16,959 | $47.0K | 0.00% | 00.0% | Unchanged |
| Stonebridge Capital Advisors LLC | 20,000 | $55.4K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 24,000 | $66.5K | 0.00% | −10,233−29.9% | Reduced |
| Citadel Advisors LLC | 24,020 | $66.5K | 0.00% | +1,305+5.7% | Added |
| Catalyst Financial Partners LLC | 36,267 | $94.3K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 66,629 | $184.6K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 91,573 | $253.7K | 0.00% | −29,422−24.3% | Reduced |
| BlackRock Inc. | 103,370 | $286.3K | 0.00% | −1,362−1.3% | Reduced |
| Aristides Capital LLC | 106,333 | $294.5K | 0.12% | 00.0% | Unchanged |
| Northern Trust Corp | 127,819 | $354.1K | 0.00% | −5,814−4.4% | Reduced |
| Susquehanna International Group, LLP | 209,332 | $579.9K | 0.00% | +181,713+657.9% | Added |
| Bleichroeder LP | 222,317 | $615.8K | 0.15% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 239,235 | $662.8K | 0.00% | +20,457+9.4% | Added |
| Paragon Associates & Paragon Associates II Joint Venture | 500,000 | $1.39M | 2.47% | 00.0% | Unchanged |
| First Manhattan Co | 850,038 | $2.35M | 0.01% | +735,294+640.8% | Added |
| Cooperman Leon G | 883,623 | $2.45M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,013,522 | $2.81M | 0.00% | +211,351+26.3% | Added |
| Altium Capital Management LP | 0 | $0 | 0.00% | −287,698−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,845−100.0% | Sold out |
| Avantax Advisory Services, Inc. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,843−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −564−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −481−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −15−100.0% | Sold out |